Literature DB >> 9169594

Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.

E G Wojcik1, M Van Den Berg, S R Poort, R M Bertina.   

Abstract

The propeptide of human coagulation factor IX (FIX) directs the gamma-carboxylation of the first 12 glutamic acid residues of the mature protein into gamma-carboxyglutamic acid (Gla) residues. The propeptide is normally removed before secretion of FIX into the blood. However, mutation of Arg-4 in the propeptide abolishes propeptide cleavage and results in circulating profactor IX in the blood. We studied three such genetic variants, factor IX Boxtel (Arg-4-->Trp), factor IX Bendorf (Arg-4-->Leu) and factor IX Seattle C (Arg-4-->Gln). These variant profactor IX molecules bind normally to anti-FIX:Mg(II) antibodies, which indicates that the mutations do not seriously affect gamma-carboxylation. Metal ion titration of the binding of variant profactor IX to conformation-specific antibodies demonstrates that the calcium-induced conformation is destabilized in the variant molecules. Also the binding of FIX Boxtel to phospholipids and its activation by factor XIa requires a high (>5 mM) calcium concentration. The three-dimensional structure of the Gla domain of FIX in the presence of calcium indicates that the acylation of the amino-terminus, rather than the presence of the propeptide, was responsible for the destabilization of the calcium-induced conformation. In order to confirm this, the alpha-amino group of Tyr1 of FIX was acetylated. This chemically modified FIX showed a similar destabilization of the calcium-induced conformation to variant profactor IX. Our data imply that the amino-terminus of FIX plays an important role in stabilizing the calcium-induced conformation of the Gla domain of FIX. This conformation is important for the binding to phospholipids as well as for the activation by factor XIa. Our results indicate that mutations in FIX that interfere with propeptide cleavage affect the function of the protein mainly by destabilizing the calcium-induced conformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169594      PMCID: PMC1218364          DOI: 10.1042/bj3230629

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Modification of amino groups in inhibitors of proteolytic enzymes.

Authors:  R Haynes; D T Osuga; R E Feeney
Journal:  Biochemistry       Date:  1967-02       Impact factor: 3.162

2.  Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX.

Authors:  S J Freedman; B C Furie; B Furie; J D Baleja
Journal:  Biochemistry       Date:  1995-09-26       Impact factor: 3.162

3.  Role of propeptide in vitamin K-dependent gamma-carboxylation.

Authors:  K J Kotkow; D A Roth; T J Porter; B C Furie; B Furie
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

Review 4.  Biosynthesis of factor IX: implications for gene therapy.

Authors:  B C Furie; B Furie
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

5.  Protein C Osaka 10 with aberrant propeptide processing: loss of anticoagulant activity due to an amino acid substitution in the protein C precursor.

Authors:  T Miyata; Y Z Zheng; T Sakata; H Kato
Journal:  Thromb Haemost       Date:  1995-10       Impact factor: 5.249

6.  Mutations which introduce free cysteine residues in the Gla-domain of vitamin K dependent proteins result in the formation of complexes with alpha 1-microglobulin.

Authors:  E G Wojcik; P Simioni; M d Berg; A Girolami; R M Bertina
Journal:  Thromb Haemost       Date:  1996-01       Impact factor: 5.249

7.  Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors.

Authors:  I Pabinger; B Schneider
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-06       Impact factor: 8.311

8.  Influence of six mutations of the protein C gene on the Gla domain conformation and calcium affinity.

Authors:  P Gaussem; S Gandrille; J Duchemin; J Emmerich; M Alhenc-Gelas; M F Aillaud; M Aiach
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

9.  Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.

Authors:  M Jacobs; S J Freedman; B C Furie; B Furie
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

10.  Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.

Authors:  E G Wojcik; M van den Berg; I K van der Linden; S R Poort; R Cupers; R M Bertina
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

View more
  2 in total

1.  Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay.

Authors:  Wenwen Gao; Yaqi Xu; Hongli Liu; Meng Gao; Qing Cao; Yiyi Wang; Longteng Cui; Rong Huang; Yan Shen; Sanqiang Li; Haiping Yang; Yixiang Chen; Chaokun Li; Haichuan Yu; Weikai Li; Guomin Shen
Journal:  Blood Adv       Date:  2020-08-11

2.  Vitamin K-dependent carboxylation of coagulation factors: insights from a cell-based functional study.

Authors:  Zhenyu Hao; Da-Yun Jin; Darrel W Stafford; Jian-Ke Tie
Journal:  Haematologica       Date:  2019-10-17       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.